enkephalin, leucine has been researched along with phosphocreatine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golikov, AP; Riabinin, VA | 1 |
| Casini, G; Conte Camerino, D; Tricarico, D | 1 |
| Abumrad, NN; Dorton, S; Garlick, PJ; Hashiguchi, Y; McNurlan, MA; Molina, PE; Reddy, D | 1 |
| Danysz, W; Dekundy, A; Quack, G; Valastro, B | 1 |
1 trial(s) available for enkephalin, leucine and phosphocreatine
| Article | Year |
|---|---|
[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
Topics: Aged; Antioxidants; Clinical Trials as Topic; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Humans; Male; Myocardial Infarction; Phosphocreatine; Piracetam; Propranolol; Sodium Oxybate; Stress, Physiological; Verapamil | 1990 |
3 other study(ies) available for enkephalin, leucine and phosphocreatine
| Article | Year |
|---|---|
Effects of high energy phosphates and L-arginine on the electrical parameters of ischemic-reperfused rat skeletal muscle fibers.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arginine; Electrophysiology; Enkephalin, Leucine; Male; Muscle, Skeletal; Phosphocreatine; Rats; Rats, Wistar; Reperfusion Injury | 1995 |
Central opiate mu-receptor-mediated suppression of tissue protein synthesis.
Topics: Adenosine Triphosphate; Animals; Bicarbonates; Carbon Dioxide; Cerebral Ventricles; Deuterium; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hydrogen-Ion Concentration; Injections, Intraventricular; Intestinal Mucosa; Kidney; Liver; Male; Muscle, Skeletal; Organ Specificity; Oxygen; Oxyhemoglobins; Partial Pressure; Phenylalanine; Phosphocreatine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Regression Analysis; Respiration; Spleen | 1997 |
Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Creatine; Dietary Supplements; Disease Models, Animal; Dyskinesia, Drug-Induced; Energy Metabolism; Enkephalins; Female; In Vitro Techniques; Levodopa; Neostriatum; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phosphocreatine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Statistics, Nonparametric | 2009 |